Does Citrus Bergamot Lower Cholesterol? An Evidence-Quality Reckoning

By Erin Rose · Updated July 19, 2026 · Methodology

Educational overview — not medical advice. No trial in this evidence base measured a hard cardiovascular outcome. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Two research traditions, laid side by side

Bergamot's cholesterol literature splits cleanly into two groups, and the honest picture only emerges from reading them against each other rather than citing one in isolation.

The four industry/institution-linked rows report the largest, most dramatic effects in the literature. The two independent rows — a systematic review and a null trial — tell a more cautious story. Both belong in the same summary; neither should be cited alone.

What the independent review actually found

Lamiquiz-Moneo 2020 is the load-bearing citation for this entire cluster. Screening 442 studies down to 12 that met eligibility criteria, it found 75% showed a significant decrease in total cholesterol, triglycerides, and LDL-C, with effect ranges spanning TC −12.3% to −31.3%, LDL-C −7.6% to −40.8%, and TG −11.5% to −39.5%, and 8 of 12 trials also reporting an HDL-C increase. That's a real, positive signal from a genuinely independent source (a Spanish lipid and atherosclerosis unit with no financial or institutional connection to bergamot). But the review's own authors state plainly: "studies had heterogeneous designs and scientific quality of studies was quite limited." Read literally, that means the review's authors — the people who read all 12 underlying trials most carefully — do not consider this settled, high-quality evidence, even while finding a real signal.

Combination products: a separate, easily confused category

Two trials in this evidence pack test bergamot as part of a multi-ingredient formula, not alone, and their results should never be attributed to bergamot by itself. Fogacci 2024 (n=90, double-blind RCT) tested a combined artichoke-plus-bergamot supplement and found significant lipid improvements — a real result for that combination product, with no way to isolate bergamot's individual contribution. Fogacci 2022 (the ANEMONE study, n=60 RCT) tested Eufortyn® Colesterolo Plus, a formula combining bergamot polyphenolic fraction phytosome, artichoke extract, CoQ10 phytosome, and zinc, funded by the product's manufacturer (Scharper S.p.A., "no role" in study conduct disclosed) — again a real finding for that specific combination, not evidence for bergamot alone. Marketing that cites either trial's effect size as "what bergamot does" is misattributing a combination-product result to a single ingredient.

The bergamot-vs-red-yeast-rice honesty check

One of the more useful independent data points in this evidence pack isn't a bergamot trial at all — it's a comparative review. Kłosiewicz-Latoszek 2021, from Poland's National Institute of Public Health, reviewed the nutraceutical cholesterol-lowering landscape and concluded that "red yeast rice and Armolipid are the most favourable for reducing cardiovascular events. However, the evidence of benefits of berberine and bergamot is not so conclusive," adding that "the opinion of experts on berberine and bergamot is ambiguous." That's a direct, independent ranking that places bergamot in a clearly lower evidence tier than red yeast rice — useful context for anyone comparing nutraceutical options rather than assuming all "natural cholesterol supplements" carry equal evidentiary weight. A broader review (Cicero 2021) takes a more favorable overview tone toward bergamot and other nutraceuticals, but its authors disclose extensive pharma/nutraceutical industry ties, including grants from companies that sell bergamot-combination products covered in this pack — weight it accordingly. A more institutionally independent overview (Arnaboldi 2022, University of Milan pharmacology department) is supportive of standardized bergamot/artichoke extracts for mild-to-moderate dyslipidemia, but like the other two reviews cited here, it is a narrative synthesis of existing data, not a new primary trial.

Compare Citrus Bergamot Products

If you're ready to buy, here's how the citrus bergamot products we track and verify compare on cost per dose.

Frequently asked questions

Related

• Citrus Bergamot: what it is & who it's for
• Citrus Bergamot for High Cholesterol — the individual trial numbers, in detail
• Dosage Guide
• Best Citrus Bergamot Supplement — ranked by standardization
• Berberine for Blood Sugar — the other nutraceutical the Kłosiewicz-Latoszek review calls "not so conclusive"

Sources